Skip to main content
Premium Trial:

Request an Annual Quote

Researchers Discover Transposable Elements Involved in Rare Disease Gene Regulation

Researchers from Queen Mary University of London identify in a study appearing in Nature Structural & Molecular Biology a family of transposable elements that control the activation of certain genes that cause a rare pediatric disease called MSL3 syndrome. While mutations in the MSL3 gene are known cause the disease, the mechanism through which MSL3 mutations lead to this syndrome was unknown, the authors note in a press release. Scientists previously thought that the MSL3 complex regulates the MSL3 genes directly by activating transposable elements. However, the QMUL team finds in its new study that a family of transposable elements known as LINE1 elements could function as a switch to turn on certain MSL3 genes. "Although these DNA elements are popularly known as jumping genes, most are immobile and not harmful. We only know the tip of the iceberg about how host species are using this virus-like DNA to our own advantage," lead author Pradeepa Madapura from QMUL says in statement. The researchers say that further research is needed to test whether drugs that alter this epigenetic pathway alleviate symptoms in children with mutations in MSL genes.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.